Thus, it is possible that mutant LRRK2 through its presynaptic actions on α-synuclein localization and glutamatergic synapse activity could cause a degeneration in dopamine terminals in the striatum, ultimately leading to Parkinson’s disease. The gene discussed is LRRK2; the disease is Parkinson disease.